Full-Life Technologies
Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing
$150MSeries D+Debt
Role not disclosedLoading investors…
Activity from announced rounds
Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing
Develops a minimally invasive implantable device to treat benign prostatic hyperplasia in men